세포치료 시장 : 세포 유형, 치료 유형, 용도, 최종 사용자별 - 세계 예측(2025-2030년)

The Cell Therapy Market was valued at USD 8.66 billion in 2023, expected to reach USD 9.60 billion in 2024, and is projected to grow at a CAGR of 10.93%, to USD 17.91 billion by 2030.

Cell therapy, a cutting-edge frontier in regenerative medicine, involves the administration of living cells to repair or replace damaged tissues and organs. The scope of this therapy spans applications in oncology, neurology, orthopedics, and cardiovascular conditions among others. Its necessity is driven by its potential to provide solutions for chronic diseases, genetic disorders, and degenerative conditions where traditional treatments fall short. End-use sectors include clinical research organizations, hospitals, and specialized cell therapy centers, all crucial for developing, testing, and applying these therapies. Market growth factors include increasing prevalence of chronic diseases, advancements in cell-based research, and favorable regulatory frameworks. The latest opportunities lie in evolving areas like personalized medicine, with CAR-T cell therapy leading the charge against specific cancers, and expanding applications in stem cell therapy. Adoption of AI and machine learning in improving cell development processes is another promising prospect. However, challenges such as complex regulatory landscapes, high production costs, and limited commercialization due to stringent policies restrain growth potential. There is also hesitancy in market acceptance stemming from ethical concerns and limited long-term efficacy data. Innovations should focus on scalable manufacturing solutions, reducing costs, and ensuring safety and efficacy through advanced clinical trials. Companies could explore partnerships with academic institutions for research synergies. The market is dynamic, marked by rapid technological evolution, necessitating players to remain agile and compliant with changing regulations. Opportunities for growth are present in developing markets where healthcare infrastructure advancements and investments in biotech are on the rise. Additionally, investing in educational campaigns to improve public perception and understanding could boost market acceptance. To succeed, stakeholders must navigate the challenges while leveraging technological and collaborative innovations to drive the adoption and success of cell therapies worldwide.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Therapy Market

The Cell Therapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing Government Investment in Biotech Innovation and Approval Rates in Cell Therapy
  • Improvements in Cell Therapy Supply Chain
• Market Restraints
  • Side Effects Related to the Stem Cell Transplant
• Market Opportunities
  • Advancements in Chimeric Antigen Receptor T-cell (CAR-T) Therapies for Cancer Treatments and the Use of ESCs (Embryonic stem cells) and iPSCs (Induced Pluripotent Stem Cells)
  • Increasing Use of Stem Cells for the Treatment of Neurological disorders
• Market Challenges
  • Ethical Issues Associated with the Use of Stem Cells and Pharmacological Issues

Porter's Five Forces: A Strategic Tool for Navigating the Cell Therapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Therapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Therapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Therapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Therapy Market

A detailed market share analysis in the Cell Therapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Therapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Therapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Cell Therapy Market, highlighting leading vendors and their innovative profiles. These include Athersys, Inc., Sartorius AG, BioNTech SE, Anterogen Co., Ltd., Takeda Pharmaceutical Company Limited, Pfizer Inc., Novartis AG, Thermo Fisher Scientific, Inc., Stempeutics Research Pvt. Ltd., Vericel Corporation, JCR Pharmaceuticals Co., Ltd., Mesoblast Ltd., Castle Creek Biosciences, Inc., FUJIFILM Holdings Corporation, Gilead Sciences, Inc., Stemedica Cell Technologies, Inc., Medipost Co., Ltd., Smith & Nephew PLC, Bone Therapeutics SA, NuVasive, Inc., Kolon TissueGene, Inc., Lonza Group Ltd., Astellas Pharma Inc., TegoScience, and Bristol-Myers Squibb Company.

Market Segmentation & Coverage

This research report categorizes the Cell Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Cell Type, market is studied across Differentiated Cell and Stem Cell.
• Based on Therapy Type, market is studied across Allogenic Therapies and Autologous Therapies.
• Based on Application, market is studied across Autoimmune Diseases, Dermatology, Musculoskeletal Therapies, and Oncology.
• Based on End-User, market is studied across Biotechnology and Pharmaceutical Companies, Hospitals and Clinics, and Research Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Government Investment in Biotech Innovation and Approval Rates in Cell Therapy
    • 5.1.1.2. Improvements in Cell Therapy Supply Chain
  • 5.1.2. Restraints
    • 5.1.2.1. Side Effects Related to the Stem Cell Transplant
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in Chimeric Antigen Receptor T-cell (CAR-T) Therapies for Cancer Treatments and the Use of ESCs (Embryonic stem cells) and iPSCs (Induced Pluripotent Stem Cells)
    • 5.1.3.2. Increasing Use of Stem Cells for the Treatment of Neurological disorders
  • 5.1.4. Challenges
    • 5.1.4.1. Ethical Issues Associated with the Use of Stem Cells and Pharmacological Issues
• 5.2. Market Segmentation Analysis
  • 5.2.1. Cell Type: Advancements in stem cells for therapeutic applications
  • 5.2.2. Therapy Type: Increasing adoption of autologous cell therapies for personalized medicines
  • 5.2.3. Application: Advancements in dermatological applications of cell therapies
  • 5.2.4. End-User: Diverse applications of cell therapies in hospitals and clinics for disease management
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Cell Therapy Market, by Cell Type

• 6.1. Introduction
• 6.2. Differentiated Cell
• 6.3. Stem Cell

7. Cell Therapy Market, by Therapy Type

• 7.1. Introduction
• 7.2. Allogenic Therapies
• 7.3. Autologous Therapies

8. Cell Therapy Market, by Application

• 8.1. Introduction
• 8.2. Autoimmune Diseases
• 8.3. Dermatology
• 8.4. Musculoskeletal Therapies
• 8.5. Oncology

9. Cell Therapy Market, by End-User

• 9.1. Introduction
• 9.2. Biotechnology and Pharmaceutical Companies
• 9.3. Hospitals and Clinics
• 9.4. Research Institutes

10. Americas Cell Therapy Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Cell Therapy Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Cell Therapy Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Pluri Launches New Cell Therapy CDMO Division
  • 13.3.2. Max Healthcare Launches CAR-T Cell Therapy to Improve Cancer Care in Delhi-NCR
  • 13.3.3. Bayer Opens First Cell Therapy Manufacturing Facility to Advance Regenerative Medicines on a Global Scale

Companies Mentioned

• 1. Athersys, Inc.
• 2. Sartorius AG
• 3. BioNTech SE
• 4. Anterogen Co., Ltd.
• 5. Takeda Pharmaceutical Company Limited
• 6. Pfizer Inc.
• 7. Novartis AG
• 8. Thermo Fisher Scientific, Inc.
• 9. Stempeutics Research Pvt. Ltd.
• 10. Vericel Corporation
• 11. JCR Pharmaceuticals Co., Ltd.
• 12. Mesoblast Ltd.
• 13. Castle Creek Biosciences, Inc.
• 14. FUJIFILM Holdings Corporation
• 15. Gilead Sciences, Inc.
• 16. Stemedica Cell Technologies, Inc.
• 17. Medipost Co., Ltd.
• 18. Smith & Nephew PLC
• 19. Bone Therapeutics SA
• 20. NuVasive, Inc.
• 21. Kolon TissueGene, Inc.
• 22. Lonza Group Ltd.
• 23. Astellas Pharma Inc.
• 24. TegoScience
• 25. Bristol-Myers Squibb Company